225 related articles for article (PubMed ID: 29771357)
1. A promotive effect for halofuginone on membrane repair and synaptotagmin-7 levels in muscle cells of dysferlin-null mice.
Barzilai-Tutsch H; Dewulf M; Lamaze C; Butler Browne G; Pines M; Halevy O
Hum Mol Genet; 2018 Aug; 27(16):2817-2829. PubMed ID: 29771357
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of muscle fibrosis and improvement of muscle histopathology in dysferlin knock-out mice treated with halofuginone.
Halevy O; Genin O; Barzilai-Tutsch H; Pima Y; Levi O; Moshe I; Pines M
Histol Histopathol; 2013 Feb; 28(2):211-26. PubMed ID: 23275304
[TBL] [Abstract][Full Text] [Related]
3. Halofuginone promotes satellite cell activation and survival in muscular dystrophies.
Barzilai-Tutsch H; Bodanovsky A; Maimon H; Pines M; Halevy O
Biochim Biophys Acta; 2016 Jan; 1862(1):1-11. PubMed ID: 26454207
[TBL] [Abstract][Full Text] [Related]
4. Early pathological signs in young dysf
Barzilai-Tutsch H; Genin O; Pines M; Halevy O
Neuromuscul Disord; 2020 Jun; 30(6):472-482. PubMed ID: 32451154
[TBL] [Abstract][Full Text] [Related]
5. Myofibers deficient in connexins 43 and 45 expression protect mice from skeletal muscle and systemic dysfunction promoted by a dysferlin mutation.
Fernández G; Arias-Bravo G; Bevilacqua JA; Castillo-Ruiz M; Caviedes P; Sáez JC; Cea LA
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165800. PubMed ID: 32305450
[TBL] [Abstract][Full Text] [Related]
6. Halofuginone improves muscle-cell survival in muscular dystrophies.
Bodanovsky A; Guttman N; Barzilai-Tutsch H; Genin O; Levy O; Pines M; Halevy O
Biochim Biophys Acta; 2014 Jul; 1843(7):1339-47. PubMed ID: 24703880
[TBL] [Abstract][Full Text] [Related]
7. Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.
Azakir BA; Di Fulvio S; Kinter J; Sinnreich M
J Biol Chem; 2012 Mar; 287(13):10344-10354. PubMed ID: 22318734
[TBL] [Abstract][Full Text] [Related]
8. Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.
Gushchina LV; Bhattacharya S; McElhanon KE; Choi JH; Manring H; Beck EX; Alloush J; Weisleder N
Mol Ther; 2017 Oct; 25(10):2360-2371. PubMed ID: 28750735
[TBL] [Abstract][Full Text] [Related]
9. Blockade of Hemichannels Normalizes the Differentiation Fate of Myoblasts and Features of Skeletal Muscles from Dysferlin-Deficient Mice.
Cea LA; Fernández G; Arias-Bravo G; Castillo-Ruiz M; Escamilla R; Brañes MC; Sáez JC
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825681
[TBL] [Abstract][Full Text] [Related]
10. Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models.
Vallecillo-Zúniga ML; Rathgeber MF; Poulson PD; Hayes S; Luddington JS; Gill HN; Teynor M; Kartchner BC; Valdoz J; Stowell C; Markham AR; Arthur C; Stowell S; Van Ry PM
PLoS One; 2020; 15(9):e0238441. PubMed ID: 32881965
[TBL] [Abstract][Full Text] [Related]
11. Dual Adeno-Associated Virus 9 with Codon-Optimized DYSF Gene Promotes In Vivo Muscle Regeneration and May Decrease Inflammatory Response in Limb Girdle Muscular Dystrophy Type R2.
Yakovlev IA; Emelin AM; Slesarenko YS; Limaev IS; Vetrova IA; Belikova LD; Grafskaia EN; Bobrovsky PA; Pokrovsky MV; Kuzubova EV; Pokrovsky VM; Lebedev PA; Bardakov SN; Isaev AA; Deev RV
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686363
[TBL] [Abstract][Full Text] [Related]
12. Serum exosomes can restore cellular function
Dong X; Gao X; Dai Y; Ran N; Yin H
Theranostics; 2018; 8(5):1243-1255. PubMed ID: 29507617
[No Abstract] [Full Text] [Related]
13. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.
Millay DP; Maillet M; Roche JA; Sargent MA; McNally EM; Bloch RJ; Molkentin JD
Am J Pathol; 2009 Nov; 175(5):1817-23. PubMed ID: 19834057
[TBL] [Abstract][Full Text] [Related]
14. Extensive mononuclear infiltration and myogenesis characterize recovery of dysferlin-null skeletal muscle from contraction-induced injuries.
Roche JA; Lovering RM; Roche R; Ru LW; Reed PW; Bloch RJ
Am J Physiol Cell Physiol; 2010 Feb; 298(2):C298-312. PubMed ID: 19923419
[TBL] [Abstract][Full Text] [Related]
15. Halofuginone inhibits Smad3 phosphorylation via the PI3K/Akt and MAPK/ERK pathways in muscle cells: effect on myotube fusion.
Roffe S; Hagai Y; Pines M; Halevy O
Exp Cell Res; 2010 Apr; 316(6):1061-9. PubMed ID: 20060825
[TBL] [Abstract][Full Text] [Related]
16. GREG cells, a dysferlin-deficient myogenic mouse cell line.
Humphrey GW; Mekhedov E; Blank PS; de Morree A; Pekkurnaz G; Nagaraju K; Zimmerberg J
Exp Cell Res; 2012 Jan; 318(2):127-35. PubMed ID: 22020321
[TBL] [Abstract][Full Text] [Related]
17. AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy.
Ono H; Suzuki N; Kanno SI; Kawahara G; Izumi R; Takahashi T; Kitajima Y; Osana S; Nakamura N; Akiyama T; Ikeda K; Shijo T; Mitsuzawa S; Nagatomi R; Araki N; Yasui A; Warita H; Hayashi YK; Miyake K; Aoki M
Mol Ther; 2020 Apr; 28(4):1133-1153. PubMed ID: 32087766
[TBL] [Abstract][Full Text] [Related]
18. Minimal expression of dysferlin prevents development of dysferlinopathy in dysferlin exon 40a knockout mice.
Yasa J; Reed CE; Bournazos AM; Evesson FJ; Pang I; Graham ME; Wark JR; Nijagal B; Kwan KH; Kwiatkowski T; Jung R; Weisleder N; Cooper ST; Lemckert FA
Acta Neuropathol Commun; 2023 Jan; 11(1):15. PubMed ID: 36653852
[TBL] [Abstract][Full Text] [Related]
19. Structure-Based Designed Nano-Dysferlin Significantly Improves Dysferlinopathy in BLA/J Mice.
Llanga T; Nagy N; Conatser L; Dial C; Sutton RB; Hirsch ML
Mol Ther; 2017 Sep; 25(9):2150-2162. PubMed ID: 28629822
[TBL] [Abstract][Full Text] [Related]
20. Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy.
Demonbreun AR; Fahrenbach JP; Deveaux K; Earley JU; Pytel P; McNally EM
Hum Mol Genet; 2011 Feb; 20(4):779-89. PubMed ID: 21127009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
